Literature DB >> 34536176

Reddit on PrEP: Posts About Pre-exposure Prophylaxis for HIV from Reddit Users, 2014-2019.

Penny S Loosier1, Kaytlin Renfro2, Monique Carry2, Samantha P Williams2, Matthew Hogben2, Sevgi Aral2.   

Abstract

Social media forums provide a window into how gay, bisexual, and other men who have sex with men talk about pre-exposure prophylaxis for HIV prevention (PrEP) outside of research contexts. To examine information exchange about this important pillar of HIV prevention, discussions around PrEP were collected from the r/askgaybros subreddit of the social media site Reddit (2014-2019). Post titles and asks were qualitatively coded to identify themes describing the primary purpose of the post. In all, 1163 PrEP posts were identified, and a 23.3-fold increase in post volume was seen from 2014 (n = 20) to 2019 (n = 466). The most common post type was a mention of PrEP in a post primarily discussing: an assessment of risk after a sexual encounter (19.2%); a sexual or romantic relationship (6.0%); or other (29.3%). Access challenges (19.1%), information seeking (17.5%), and the cultural effects of PrEP on the gay community (16.3%) were other common themes. Posts regarding the initiation of PrEP (11.8%) and PrEP side-effects (9.4%) were moderately represented. Posts addressing promotion, shade, stigma, and usage were infrequent (≤ 5.5% of posts, respectively). Over time, discussion of PrEP has increased exponentially on r/askgaybros, which may reflect the normalization of PrEP. Qualitative analysis of these posts can be a rich source of data for scientists, practitioners, and healthcare providers interested in increasing uptake of PrEP and decreasing barriers to its use.
© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Keywords:  Gay, bisexual, and other men who have sex with men; HIV; Pre-exposure prophylaxis; Reddit; Social media

Mesh:

Year:  2021        PMID: 34536176     DOI: 10.1007/s10461-021-03463-x

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  31 in total

1.  Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.

Authors:  Robert M Grant; Peter L Anderson; Vanessa McMahan; Albert Liu; K Rivet Amico; Megha Mehrotra; Sybil Hosek; Carlos Mosquera; Martin Casapia; Orlando Montoya; Susan Buchbinder; Valdilea G Veloso; Kenneth Mayer; Suwat Chariyalertsak; Linda-Gail Bekker; Esper G Kallas; Mauro Schechter; Juan Guanira; Lane Bushman; David N Burns; James F Rooney; David V Glidden
Journal:  Lancet Infect Dis       Date:  2014-07-22       Impact factor: 25.071

2.  Ending the HIV Epidemic: A Plan for the United States.

Authors:  Anthony S Fauci; Robert R Redfield; George Sigounas; Michael D Weahkee; Brett P Giroir
Journal:  JAMA       Date:  2019-03-05       Impact factor: 56.272

3.  Awareness, Willingness, and Perceived Efficacy of Pre-exposure Prophylaxis among Adolescent Sexual Minority Males.

Authors:  Alvin Gordián-Arroyo; Robert Garofalo; Lisa M Kuhns; Cynthia Pearson; Josh Bruce; D Scott Batey; Asa Radix; Uri Belkind; Marco A Hidalgo; Sabina Hirshfield; Eric W Schrimshaw; Rebecca Schnall
Journal:  J Urban Health       Date:  2020-10       Impact factor: 3.671

4.  Prevalence and Correlates of Medicinal Cannabis Use Among Adolescents.

Authors:  Jeffrey D Wardell; Sergio Rueda; Tara Elton-Marshall; Robert E Mann; Hayley A Hamilton
Journal:  J Adolesc Health       Date:  2020-08-20       Impact factor: 5.012

5.  Potential Impact of Interventions to Enhance Retention in Care During Real-World HIV Pre-Exposure Prophylaxis Implementation.

Authors:  Philip A Chan; William C Goedel; Amy S Nunn; Genoviva Sowemimo-Coker; Omar Galárraga; Mattia Prosperi; Rupa Patel; Leandro Mena; Madeline C Montgomery; Brandon D L Marshall
Journal:  AIDS Patient Care STDS       Date:  2019-10       Impact factor: 5.078

6.  Awareness, Willingness, and Use of Pre-exposure Prophylaxis Among Men Who Have Sex With Men in Washington, DC and Miami-Dade County, FL: National HIV Behavioral Surveillance, 2011 and 2014.

Authors:  Rudy Patrick; David Forrest; Gabriel Cardenas; Jenevieve Opoku; Manya Magnus; Gregory Phillips; Alan Greenberg; Lisa Metsch; Michael Kharfen; Marlene LaLota; Irene Kuo
Journal:  J Acquir Immune Defic Syndr       Date:  2017-07-01       Impact factor: 3.731

7.  High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project.

Authors:  Stephanie E Cohen; Eric Vittinghoff; Oliver Bacon; Susanne Doblecki-Lewis; Brian S Postle; Daniel J Feaster; Tim Matheson; Nikole Trainor; Robert W Blue; Yannine Estrada; Megan E Coleman; Richard Elion; Jose G Castro; Wairimu Chege; Susan S Philip; Susan Buchbinder; Michael A Kolber; Albert Y Liu
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-01       Impact factor: 3.731

8.  Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.

Authors:  Albert Y Liu; Stephanie E Cohen; Eric Vittinghoff; Peter L Anderson; Susanne Doblecki-Lewis; Oliver Bacon; Wairimu Chege; Brian S Postle; Tim Matheson; K Rivet Amico; Teri Liegler; M Keith Rawlings; Nikole Trainor; Robert Wilder Blue; Yannine Estrada; Megan E Coleman; Gabriel Cardenas; Daniel J Feaster; Robert Grant; Susan S Philip; Richard Elion; Susan Buchbinder; Michael A Kolber
Journal:  JAMA Intern Med       Date:  2016-01       Impact factor: 21.873

Review 9.  Going global: the adoption of the World Health Organization's enabling recommendation on oral pre-exposure prophylaxis for HIV.

Authors:  Ioannis Hodges-Mameletzis; Shona Dalal; Busisiwe Msimanga-Radebe; Michelle Rodolph; Rachel Baggaley
Journal:  Sex Health       Date:  2018-11       Impact factor: 2.706

10.  Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

Authors:  Sheena McCormack; David T Dunn; Monica Desai; David I Dolling; Mitzy Gafos; Richard Gilson; Ann K Sullivan; Amanda Clarke; Iain Reeves; Gabriel Schembri; Nicola Mackie; Christine Bowman; Charles J Lacey; Vanessa Apea; Michael Brady; Julie Fox; Stephen Taylor; Simone Antonucci; Saye H Khoo; James Rooney; Anthony Nardone; Martin Fisher; Alan McOwan; Andrew N Phillips; Anne M Johnson; Brian Gazzard; Owen N Gill
Journal:  Lancet       Date:  2015-09-09       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.